Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

SZSE:301093 株式レポート

時価総額：CN¥2.8b

Jiangsu Hualan New Pharmaceutical MaterialLtd 将来の成長

Future 基準チェック /56

Jiangsu Hualan New Pharmaceutical MaterialLtd is forecast to grow earnings and revenue by 43.1% and 28% per annum respectively. EPS is expected to grow by 41% per annum. Return on equity is forecast to be 7.5% in 3 years.

主要情報

43.1%

収益成長率

41.0%

EPS成長率

Medical Equipment 収益成長27.5%
収益成長率28.0%
将来の株主資本利益率7.5%
アナリストカバレッジ

Low

最終更新日07 Sep 2024

今後の成長に関する最新情報

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Sep 03
Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

Jun 07
Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

業績と収益の成長予測

SZSE:301093 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20261,158248N/A2431
12/31/2025898176N/A1911
12/31/2024722129N/A1671
9/30/20245928114215N/A
6/30/2024604953263N/A
3/31/202459395-6252N/A
12/31/2023623118-73224N/A
9/30/2023631106-124160N/A
6/30/202361998-118133N/A
3/31/202361096-129109N/A
1/1/202358494-7995N/A
9/30/202258610845178N/A
6/30/202269116490207N/A
3/31/2022784206114243N/A
1/1/202282121693217N/A
9/30/202178421466150N/A
6/30/202163315152116N/A
3/31/202150910361102N/A
12/31/20204468194133N/A
12/31/2019460955686N/A
12/31/20184348687107N/A
12/31/201738877N/A34N/A

アナリストによる今後の成長予測

収入対貯蓄率: 301093's forecast earnings growth (43.1% per year) is above the savings rate (2.9%).

収益対市場: 301093's earnings (43.1% per year) are forecast to grow faster than the CN market (25.8% per year).

高成長収益: 301093's earnings are expected to grow significantly over the next 3 years.

収益対市場: 301093's revenue (28% per year) is forecast to grow faster than the CN market (14% per year).

高い収益成長: 301093's revenue (28% per year) is forecast to grow faster than 20% per year.

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 301093's Return on Equity is forecast to be low in 3 years time (7.5%).

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y